Clinical Trials in Ohio

Showing 2201-2220 of 17,983 trials

TVMR With the INNOVALVE System Trial - Early Feasibility Study

NCT04919980

Study to evaluate the safety and performance of the INNOVALVE system

Mitral Valve Regurgitation (Degenerative or Functional)

Edwards Lifesciences65 participantsStarted Sep 2022

Los Angeles, California, United States • Naples, Florida, United States • Atlanta, Georgia, United States +14 more locations

Active Not RecruitingPhase 132 miles

GDNF Gene Therapy for Multiple System Atrophy

NCT04680065

The objective of this randomized, double-blinded, placebo-controlled Phase 1 investigation is to evaluate the safety and potential clinical effect of AAV2-GDNF delivered to the putamen in subjects with either a possible or probable diagnosis of Multiple System Atrophy.

Multiple System Atrophy

Brain Neurotherapy Bio, Inc.9 participantsStarted Oct 2023

Irvine, California, United States • Boca Raton, Florida, United States • Boston, Massachusetts, United States +4 more locations

TVMR With the INNOVALVE System Trial - Early Feasibility Study

GDNF Gene Therapy for Multiple System Atrophy

Find Trials by Condition in Ohio

Janus Feasibility Study

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms

Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial

A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma.

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

Supporting Evidence-based Responses to Emotional Needs in Emphysema

Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)

Teplizumab in Pediatric Stage 2 Type 1 Diabetes

A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age

A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women

Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)